One Health News
|Found 1117 Matching Results. View archived News Here.
|One Health website launched for “The Yale Human Animal Medicine Project”: a center for "One Health" studies at Yale - Thursday, October 28, 2010
One Health website launched for “The Yale Human Animal Medicine Project”: a center for "One Health" studies at Yale
The One Health Initiative website has been notified on October 26, 2010 by physician, Peter Rabinowitz, MD, MPH about a valuable new One Health project and website launched at Yale.
Please see http://tools.medicine.yale.edu/humananimalmedicine/index.html
“Recent events have highlighted the convergence and interconnectedness of human, animal, and environmental health. Recent examples include:
· the 2009 global pandemic of novel H1N1 influenza A,
· melamine poisonings in pets and infants,
· harmful algae blooms affecting marine and terrestrial animals and humans,
· the concurrent obesity epidemic in both humans and dogs and cats in the U.S.
The Yale Human Animal Medicine Project is working to pioneer useful clinical approaches to these problems and build bridges between human, animal, and environmental health using a comparative “One Health” approach.” …
For further information, contact founder and director,
Dr. Peter Rabinowitz:
(203) 785-4197 - Office
(203) 785-4197 - Clinic
(203) 785-7391 - Fax
Email address: email@example.com
Location - Patient Care
Yale Occupational and Environmental Medicine
135 College Street 392, 3rd Floor
New Haven, CT 06510
Yale Occupational and Environmental Medicine
135 College Street
New Haven, CT 06510
Note: Dr. Rabinowitz, prominent American public health physician at Yale Medical School and Dr. Lisa Conti [DVM, MPH], notable American public health veterinarian and director of environmental health at the Florida State Health Department (USA), published a groundbreaking ‘first of its kind’ One Health book December 18, 2009 entitled Human-Animal Medicine – Clinical Approaches to Zoonoses, Toxicants and other Shared Health Risks http://www.us.elsevierhealth.com/product.jsp?isbn=9781416068372
|One Health Newsletter Fall Issue now online – October 28, 2010 - Thursday, October 28, 2010
One Health Newsletter Fall Issue now online – October 28, 2010
A product of the Florida Department of Health (USA), Division of Environmental Health
Editor: Mary Echols, DVM, MPH
|U.S. Centers for Disease Control and Prevention (CDC) One Health Office Launches Historic ONE HEALTH Website - Tuesday, October 26, 2010
U.S. Centers for Disease Control and Prevention (CDC) One Health Office Launches Historic ONE HEALTH Website
The One Health Initiative website was notified October 25, 2010 that the United States Centers for Disease Control and Prevention’s (CDC) office of One Health has launched their new ONE HEALTH website:
Please see the website’s related links at http://www.cdc.gov/onehealth/related.html
The One Health movement has expanded exponentially in the U.S. and globally during these last few years. The CDC’s new Office of One Health and their One Health website represent an important and significant historic landmark of recognition for the public health community.
The CDC (http://www.cdc.gov/) has long been recognized as the premier public health agency of the U.S. government.
“For over 60 years, CDC has been dedicated to protecting health and promoting quality of life through the prevention and control of disease, injury, and disability. We are committed to programs that reduce the health and economic consequences of the leading causes of death and disability, thereby ensuring a long, productive, healthy life for all people.”
Centers for Disease Control and Prevention (CDC) 1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO 800-232-4636 TTY: (888) 232-6348 24 Hours/Every Day - firstname.lastname@example.org
The current CDC Director is Thomas R. Frieden, MD, MPH. Dr. Frieden took the helm as director of the Centers for Disease Control and Prevention (CDC) and administrator of the Agency for Toxic Substances and Disease Registry on June 8, 2009.
The One Health Initiative website’s pro bono, autonomous team of Laura H. Kahn, MD, MPH, MPP, Bruce Kaplan, DVM, Thomas P. Monath, MD, and Jack Woodall, PhD applauds this One Health advancement.
Notification provided by:
Alison Laing, MPH
ORISE Fellow, One Health Office
Division of High-Consequence Pathogens & Pathology
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
1600 Clifton Road, MS A-30
Atlanta, Georgia 30333
Addendum (October 27, 2010):
Joan Hendricks, VMD, PhD, Dean, University of Pennsylvania’s School of Veterinary Medicine (one of the earliest institutions in the U.S. to recognize the enormous value of One Health principles) wisely pointed out to the One Health Initiative website that it should be noted that there are many past, current and potential future interdisciplinary professions co-equally important to the advancement of One Health. In addition to physicians, veterinarians, and health scientists, Dr. Hendricks correctly recognizes the significance of including osteopaths, nurses, dentists and other allied health professionals.
| “The global eradication of rinderpest and its significance for “One World, One Health” - Friday, October 22, 2010
The following is a preview abstract of a “Rinderpest” presentation to be given by Dr. Paul Gibbs at:
The One Health Initiative Symposium: Vaccination of Animals for Prevention and Control of Zoonotic Diseases
American Society for Tropical Medicine and Hygiene – 59th Annual Meeting - www.astmh.org
November 3-7, 2010
Marriott Atlanta Marquis Hotel
Atlanta, Georgia (USA)
A symposium organized jointly by members of the ASTMH and the Society for Tropical Veterinary Medicine (STVM) http://www.soctropvetmed.org/ deals with the broad subject of One Health.
Marriott – Room A704, Thursday, November 4, 2010, 3:45 p.m. – 5:30 p.m.
The Symposium focuses on vaccines, considered the most cost effective means of disease prevention. The role of vaccines in preventing the spread of disease from animals to humans will be explored. Speakers will address examples where vaccination in animal species (livestock, poultry and wildlife) for zoonotic disease agents is used or could be used in order to reduce the risk of human disease.
Specific examples are drawn from important human diseases cause by viral agents of animals. Speakers will address the potential for additional impact on disease risk reduction for selected vaccine-preventable diseases as well as opportunities for vaccine interventions.
Recognition of the Global Eradication of Rinderpest
“The global eradication of rinderpest and its significance for “One World, One Health”
Rinderpest has been known for many millennia, and, wherever it occurred, it has been the most dreaded animal disease, strongly affecting livestock, rural livelihoods and food security. It is an acute, highly contagious, viral disease of cattle, domesticated buffalo and some species of wildlife. At one time, epidemics of rinderpest occurred regularly in Eurasia. In 1889, cattle shipped from India carried the rinderpest virus to Africa, causing an epidemic that established the virus on the continent. Initially, approximately 90% of the cattle in sub-Saharan Africa and many sheep and goats died. Wild buffalo, giraffe and wildebeest populations were decimated. The loss of plow animals, herds, and hunting resulted in mass starvation, killing an estimated third of the human population in Ethiopia and two-thirds of the Maasai people of Tanzania. The reduction in the number of grazing animals also allowed thickets to form in grasslands. These thickets provided breeding grounds for tsetse flies, resulting in an outbreak of sleeping sickness in humans. Some consider this epidemic to have been the most catastrophic natural disaster ever to affect Africa.
In 1994, the Global Rinderpest Eradication Programme (GREP) was launched with FAO spearheading an initiative to consolidate gains in rinderpest control and to move towards disease eradication. In close association with the World Organization for Animal Health (OIE), GREP was conceived as an international coordination mechanism to promote the global eradication of rinderpest and verification of rinderpest freedom. From the outset, this ambitious initiative set its goal for global rinderpest eradication by 2010. This is the second time that a disease has been eradicated worldwide after smallpox in humans. As with *smallpox, the eradication of rinderpest was based on the use of vaccination. In some countries, rinderpest vaccination created opportunities for “One Health” teams to operate in the villages thereby increasing the vaccination rate of children.
The eradication of rinderpest was accomplished by a world-wide commitment and support to:
1. establish the geographical distribution and epidemiology of the disease;
2. contain rinderpest within the infected eco-systems;
3. eliminate reservoirs of infection through rigorous early detection, reporting and response systems.
Once evidence accumulated that the virus had apparently been eradicated, activities progressively focused on establishing surveillance systems to prove the absence of the disease. This model emphasizes the basic requirements that are needed for effective disease prevention, control and elimination, and validates the importance of sustainable programs to address current and future infectious disease threats under the umbrella of “One Health”.
See http://www.fao.org/news/story/en/item/46383/icode/ for more information.
Paul Gibbs, BVSc, PhD, FRCVS, University of Florida, Tammy Beckham, DVM, PhD, Texas A&M University, and Karen Becker, DVM, MPH, Senior Animal Health Advisor, USAID and USDA
Dr. Paul Gibbs
Associate Dean for Students and Instruction
Professor of Virology
Office for Students and Instruction Suite V1-100
College of Veterinary Medicine
University of Florida
Gainesville, Florida 32610, USA
E-mail email@example.com Office Tel 1-352-294-4272 Desk Tel 1-352-294-4233 Mobile Tel 1-352-339-3650
ONE HEALTH (One Medicine) Supporter
D.A.Henderson, MD, MPH
Professor of Medicine and Public Health, University of Pittsburgh. Resident Scholar, Center for Biosecurity, U. of Pittsburgh Medical Center.
Johns Hopkins University Distinguished Service Professor. Dean Emeritus, Johns Hopkins Bloomberg School of Public Health.
Pier IV Building, Suite 210, Baltimore,
*April 22, 2007 Dr. D. A. Henderson, legendary leader of the worldwide smallpox eradication program.
“I thank you for your email and congratulate you and your colleagues in promoting the "One Medicine" concept. It is an initiative that is long overdue but, at the same time, I don't personally identify dramatic solutions that are apt to change the landscape in the short term. I would note that when one has had the good fortune to have enjoyed the tutelage of Jim Steele [DVM, MPH] during my tenure at CDC and periodically ever since, as a friend, the one medicine concept becomes well engrained. Indeed, when I came to Hopkins as Dean in 1977, I cast about to determine how we might link up with a veterinary school for research and educational purposes. Unfortunately, geography was simply too great a hurdle to overcome.
Bottom line: I would be more than happy to do whatever I could in support of your efforts.”
|One Health History Study Award Granted To London Imperial College (UK) from Wellcome Trust - Wednesday, October 20, 2010
One Health History Study Award Granted To London Imperial College (UK) from Wellcome Trust
“The Centre for the History of Science, Technology and Medicine at Imperial
College London, England, has won a prestigious, 5-year award from the
Wellcome Trust to study the history of One Health. Worth over £0.5m
[over $792,000 at current U.S. dollar exchange rate], it
will involve five researchers working over a five year period. The project
will be led by Dr. Abigail Woods, senior lecturer in medical history and a
qualified veterinary surgeon.
While the importance of a One Health approach to human and animal disease
is now widely recognised, its application is not always straightforward.
History will be used to help explain this situation.
During the late 19th century golden age, scientists like Virchow, Pasteur,
Theobald Smith and John McFadyean straddled the human-animal divide and
made significant breakthroughs. Subsequently, however, barriers developed
between human and animal health, preventing the pursuit of One Health. The
circumstances under which these barriers developed are not fully
understood. Moreover, the barriers were not universal: in certain times and
places, animal and human diseases were investigated together.
By studying the history of research into human and animal disease, in Western Europe
and North America, from 1850 to the present day, our programme of research
will examine the social, political, economic and scientific factors that
both impeded - and in some cases, enabled - a One Health approach. It is
hoped that the findings will help the One Health initiative's efforts to
forge closer collaborations between physicians, veterinarians and other
health professionals, while also providing new insights into the history of
human and animal health.”
Information provided October 19, 2010 by:
Abigail Woods, MA, MSc, VetMB, PhD, MRCVS
Senior lecturer in the history of medicine
Centre for the History of Science, Technology and Medicine
Imperial College London
South Kensington Campus
London SW7 2AZ (UK)
E-mail inquiries: firstname.lastname@example.org
|One Health in ACTION – 2nd Article in Tuberculosis Series - Human tuberculosis caused by Mycobacterium bovis in the United States, Latin America and the Caribbean - Monday, October 18, 2010
One Health in ACTION – 2nd Article in Tuberculosis Series
Human tuberculosis caused by Mycobacterium bovis in the United States, Latin America and the Caribbean
By de Kantor I N, LoBue P A, Thoen C O. [Dr. Isabel de Kantor is a PhD; Dr. Philip LoBue is a physician; and Dr. Charles Thoen is a veterinarian]
[Serialised article. Tuberculosis: a re-emerging disease in animals and humans. Number 3 in the series]
or directly to the pdf http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/59172528.1/iuatld/ijtld/2010/00000014/00000011/art00003/B18398FF23C661B012873887676840D4A8D74F1D28.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf
Clare Pierard | Managing Editor
International Journal of Tuberculosis and Lung Disease (IJTLD)
International Union Against Tuberculosis and Lung Disease
68, boulevard Saint-Michel | 75006 Paris | France
Tel: (+33) 1 44 32 03 60 | Fax: (+33) 1 43 29 90 83
CPierard@theunion.org | email@example.com | www.theunion.org
|One Health in ACTION: Significant New One Health Oriented “Infection, Ecology and Epidemiology Network (IEE)” Established in Sweden - 2010 - Wednesday, October 13, 2010
One Health in ACTION:
Significant New One Health Oriented “Infection, Ecology and Epidemiology Network (IEE)” Established in Sweden
Read More on Home page: www.infee.se
“Combating and controlling zoonotic infections effectively, requires an approach where researchers use the “One World – One Health” perspective. The purpose of the IEE network is to stimulate interdisciplinary projects resulting in increased knowledge of emergence, spread and effects of infectious disease on human, domestic animals and wildlife. … .”
Infection, Ecology and Epidemiology, IEE network is a Swedish national collaboration for researchers with interest in zoonotic infections. As a consequence, some of the information on this website can only be found in Swedish. We apologise for any inconvenience and kindly ask you to contact IEE if you have questions and comments.
IEE is an integration concept including several universities and governmental organizations that wish to contribute to a sustainable intellectual platform where veterinarians, physicians, molecular biologists, ecologists and environmental chemists with an interest in zoonotic infections can interact and create synergies. The rationale is not to build up new laboratory facilities, but to use and collaborate within already established research structures.
National Veterinary Institute, SVA
Swedish Agricultural University, SLU
Linnaeus University, Kalmar
Physical location: SVA, Ulls väg 2A, 751 89 Uppsala, Sweden
Project Leader: Björn Olsen, MD, PhD professor in infectious disease at Uppsala University and senior physician at Uppsala Academic Hospital. Dr. Olsen is an ornithologist with an interest in the consequences of interactions between humans, domestic animals and wildlife.
Project coordinator: Lovisa Svensson, PhD, SVA/Uppsala University
Communication officer webb: Eva Haxton, MSci, Uppsala Academic Hospital
Information Provided by:
Lovisa Svensson, PhD
Infection Ecology and Epidemiology network
Footnote: The One Health Initiative website team of Laura H. Kahn, MD, MPH, MPP, Bruce Kaplan, DVM, Thomas P. Monath, MD, and Jack Woodall, PhD strongly supports this new and exciting One Health program. Our team works with IEE both collaboratively and via reciprocal website links: please see http://www.infee.se/infee/node/6 and One Health Initiative website NEWS Statistics http://www.onehealthinitiative.com/news.php posted on the News page (scroll down).
|One Health - 2010 AAVLD/USAHA Plenary Sessions - Nov 13 & 15 - Monday, October 11, 2010
2nd Reminder: IMPORTANT ONE HEALTH MEETING SESSIONS ANNOUNCED August 7, 2010:
November 11-17, 2010
United States Animal Health Association (USAHA)
114th Annual Meeting - Minneapolis, Minnesota (USA)
American Association of Veterinary Laboratory Diagnosticians (AAVLD)
53rd Annual Conference
For more information on AAVLD programs, please go to www.aavld.org
One Health - 2010 AAVLD/USAHA Plenary Sessions
Saturday, 13 Nov 2010
AAVLD Plenary Session – 7:50 – 11:30 a.m.
One Health: Opportunities for Veterinary Diagnostic Laboratories
7:50 a.m. Welcome – Craig Carter, DVM, PhD, AAVLD President-Elect
8:00 Keynote-- Human-Animal Medicine Title: How Do Laboratories Fit Into the Picture?
- Peter Rabinowitz, MD, MPH
8:30 NBAF And Its Role In the Growing One Health Initiative
– Cyril Gay, DVM, PhD
9:00 What are the Challenges and Pitfalls to my Laboratory Participating in One Health?
– Bruce Akey, MS, DVM
10:00 Valuing One Health: Opportunities and Challenges for Veterinary Diagnostic Laboratories
– Tammy Beckham, DVM, PhD
10:30 When/Where/How Veterinarians Can Build Bridges Between the Diagnostic Laboratory and the Local Health Community –
-Tanya Graham, DVM, DAVCP
11:00 a.m. Walk the Talk: The Center for Excellence of Emerging & Zoonotic Animal Diseases (CEEZAD) and One Health –
-Juergen Richt, DVM, PhD
Monday, 15 Nov 2010
USAHA/AAVLD Joint Plenary Session – 7:50 – 12:00 a.m.
One Health: One Way Street Or Are There Opportunities for Animal Agriculture?
7:50 a.m. Welcome – Steve Halstead, DVM, MS USAHA President-Elect; Lonnie King, DVM, MS, MPA Moderator
8:00 Keynote--One Medicine: Its All Herd Health
– Lisa A. Conti, DVM, MPH
8:30 Emerging Infectious Diseases: The Case for Integrating
Science, Medicine and Public Health
- Gary Simpson, MD, PhD, MPH
9:00 Producer perspective on One Health: What are the implications of being a One Health Partner
- Mark Engle. DVM, MS
10:00 One Health and the Environment: Improving Health in a Wicked World
- Katie Pelican, DVM, PhD
10:30 Global prospective of One Health: Are we missing opportunities?
- Mo Salman, DVM, MPVM, PhD
11:00 Emerging Microbial Threats: Challenges and Opportunities at the Human-Animal-Ecosystem Interface
-James M. Hughes, MD
11:30 One Health Discussion and Q&A Panel
Dr. Craig N. Carter
Director & Professor, Epidemiology
Livestock Disease Diagnostic Center
Department of Veterinary Science
Colleges of Agriculture & Public Health
University of Kentucky
1490 Bull Lea Rd.
Lexington, KY 40511
|Press Release (received October 6, 2010): Agricultural Science and Politics - Thursday, October 07, 2010
Press Release (received October 6, 2010):
Agricultural Science and Politics
October 5, 2010—Dr. Juergen A. Richt [DVM, PhD], Kansas State University Regents Distinguished Professor and Director of CEEZAD, (Center of Excellence for Emerging and Zoonotic Animal Diseases), speaking at the Farm Foundation Conference on September 24, 2010, “Zoonoses: Understanding the Animal Agriculture and Human Health Connection” in Washington, DC, set out the links between politics, One Health and communication. He emphasized that “the search for the public health of the nation is a political pursuit, because we are competing with other policy objectives, other priorities and many special interests.” “We must affirm,” he said, “the relevance of politics in a democratic society and communicate with politicians in their hopes, agendas and concerns, even if their primary concern appears at times to be re-elected. I believe that it is our task to convince the politicians that if they want to be re-elected they need to support us in our pursuit to improve public health.”
In striving to achieve this goal of sound public health, Dr. Richt noted that “it is essential to unite human and veterinary medicine with ecological health, in a commitment to ‘One Health—One Medicine—One Environment.’ If we try to protect people without protecting animals and the environment, the result will be that people, animals and the environment will all suffer needlessly. Therefore, we need to support the One Health Initiative that seeks to unify human and veterinary medicine.” However, he noted that even with an awareness of the importance of politics and One Health, it was essential “to learn to be effective communicators to achieve our policy objectives.”
Intriguingly, Dr. Richt suggested that “the closer you get to a brick wall, the better you can see the door in that wall. The brick wall is our own limitations; and the door in that brick wall is not always open, because it is a swinging door that is moving us back and forth from scientific issues to political issues. We all need to take the opportunity to move through that swinging door at the appropriate time on the appropriate issues.”
Dr. Richt concluded that, “whether our primary concern is scientific, agricultural, veterinary medicine, public health, ecohealth or political, we can all learn to communicate effectively, with both our friends and those who think they are our enemies. If we fail to communicate, we fail as scientists.”
For further information, please contact Karinne Cortes firstname.lastname@example.org or 785-532-2793
|Breast Cancer Awareness Month This October - One Health in ACTION: Human Breast Cancer Comparative Medicine Research Advances at MD Anderson Cancer Center - Wednesday, October 06, 2010
Breast Cancer Awareness Month This October
This previous News item is how “One Health” comparative medicine has advanced critical scientific knowledge about Breast Cancer: think of what full One Health implementation and institutionalization could achieve!
One Health in ACTION: Human Breast Cancer Comparative Medicine Research Advances at MD Anderson Cancer Center - Friday, September 17, 2010
One Health in ACTION: Human Breast Cancer Comparative Medicine Research Advances at MD Anderson Cancer Center
Physicians, PhDs, and Veterinarians working collaboratively and synergistically
Department of Veterinary Sciences, Michale E. Keeling Center for Comparative Medicine and Research, The University of Texas
Provided September 13, 2010 by:
Christian R. Abee, DVM, MS, DACLAM
Doctor R. Lee Clark Professor and Chair
Department of Veterinary Sciences
Director, Michale E. Keeling Center for Comparative Medicine and Research
University of Texas MD Anderson Cancer Center
Bastrop, TX 78602
Telephone: (512) 321-3991 begin_of_the_skype_highlighting (512) 321-3991 end_of_the_skype_highlighting
Research at the Keeling Center has led to discovery of new breast cancer therapeutic monoclonal antibodies, and the development of early breast cancer tests based on the antibodies. These antibodies were discovered in the laboratory of Keeling Center investigator Dr. Feng Wang-Johanning [MD, PhD] and her Keeling Center collaborator, Dr. Gary Johanning [PhD]. The monoclonal antibodies are directed against an ancient retrovirus that originated outside the human body as a remnant of an exogenous retrovirus, and subsequently became incorporated into the genome of primates millions of years ago. This retrovirus, termed human endogenous retrovirus (HERV), currently resides in the genome of all humans.
Dr. Wang-Johanning and Dr. Johanning are focusing their studies on one highly active subgroup of HERV, HERV type K. HERV-K is not usually expressed in normal, non-cancer cells, but they found that its expression re-emerges in human breast cancer, making it a good target for antibody therapy. Dr. Wang-Johanning’s major research discovery to date is that monoclonal and single chain antibodies against HERV-K are effective in inhibiting breast cancer cell proliferation and inducing cell cycle arrest and apoptosis, both in vitro and in vivo. Pivotal studies in immunodeficient mice demonstrated that tumor sizes were significantly reduced, and onset of tumorigenesis was significantly delayed, in antibody-treated mice bearing breast tumors.
HERV-K is thus a novel antigen target for breast cancer, and Dr. Wang-Johanning’s pre-clinical studies provide compelling evidence that antibodies to HERV-K have the potential to be effective therapeutic agents for treating breast cancer. She is currently developing humanized and human antibodies for clinical trials, aimed at translating her laboratory results to breast cancer patients. Drs. Wang-Johanning and Johanning are hopeful that this antibody will rival the effectiveness of the well-known breast cancer therapeutic antibody Herceptin. There is reason for their optimism, because while Herceptin is effective against only 25-30 percent of breast cancers, anti-HERV-K antibodies have the potential to be effective against almost all human breast cancers.
The research of Dr. Wang-Johanning and collaborators has just taken an exciting turn. They are taking advantage of the presence of HERV-K in breast cancer to develop early breast cancer tests. These tests are based on detection of anti-HERV-K serum antibodies and viral RNA, and will be analogous to the PSA test that is widely used for prostate cancer screening. There is a need for these tests, because currently there are no sensitive and specific serum tests for breast cancer.
These discoveries would not have been possible without “One Health” collaboration between Dr. Wang-Johanning’s group and investigators at the main M. D. Anderson Cancer Center campus in Houston. Kelly Hunt, MD, breast cancer surgeon, provided breast cancer serum and tumor tissues for Dr. Wang-Johanning’s projects. In addition, Stephan Ambs, PhD, National Cancer Institute, is collaborating with Dr. Wang-Johanning’s laboratory to assess the clinical significance of elevated HERV-K in breast cancer. Bruce Bernacky, DVM at the Keeling Center, will also play a prominent role in upcoming studies with Dr. Wang-Johanning because he will provide access to primates for testing her antibodies prior to human clinical trials.
Note: Please see the current issue of the Institute of Laboratory Animal Research (ILAR) Journal which contains “One Health: The Intersection of Humans, Animals and the Environment – Scientific Editor: James G. Fox, DVM, MS [2010 Volume 51, Number 3]
ILAR Journal and ILAR e-Journal
The National Academies
500 Fifth Street, NW
Washington, DC 20001
202-334-2590 begin_of_the_skype_highlighting 202-334-2590 end_of_the_skype_highlighting
Cameron Fletcher, Managing Editor email@example.com”